Altiok S - Search Results

1

Heregulin induces phosphorylation of BRCA1 through phosphatidylinositol 3-Kinase/AKT in breast cancer cells.

Altiok S, Batt D, Altiok N, Papautsky A, Downward J, Roberts TM, Avraham H. Altiok S, et al. Among authors: altiok n. J Biol Chem. 1999 Nov 5;274(45):32274-8. doi: 10.1074/jbc.274.45.32274. J Biol Chem. 1999. PMID: 10542266 Free article.

2

Heregulin-stimulated acetylcholine receptor gene expression in muscle: requirement for MAP kinase and evidence for a parallel inhibitory pathway independent of electrical activity.

Altiok N, Altiok S, Changeux JP. Altiok N, et al. Among authors: altiok s. EMBO J. 1997 Feb 17;16(4):717-25. doi: 10.1093/emboj/16.4.717. EMBO J. 1997. PMID: 9049301 Free PMC article.

3

JNK pathway regulates estradiol-induced apoptosis in hormone-dependent human breast cancer cells.

Altiok N, Koyuturk M, Altiok S. Altiok N, et al. Among authors: altiok s. Breast Cancer Res Treat. 2007 Nov;105(3):247-54. doi: 10.1007/s10549-006-9451-1. Epub 2006 Dec 23. Breast Cancer Res Treat. 2007. PMID: 17187235

4

A plant oxylipin, 12-oxo-phytodienoic acid, inhibits proliferation of human breast cancer cells by targeting cyclin D1.

Altiok N, Mezzadra H, Patel P, Koyuturk M, Altiok S. Altiok N, et al. Among authors: altiok s. Breast Cancer Res Treat. 2008 May;109(2):315-23. doi: 10.1007/s10549-007-9658-9. Epub 2007 Jul 19. Breast Cancer Res Treat. 2008. PMID: 17638069

5

PPARgamma induces cell cycle withdrawal: inhibition of E2F/DP DNA-binding activity via down-regulation of PP2A.

Altiok S, Xu M, Spiegelman BM. Altiok S, et al. Genes Dev. 1997 Aug 1;11(15):1987-98. doi: 10.1101/gad.11.15.1987. Genes Dev. 1997. PMID: 9271121 Free PMC article.

6

Assessment of gefitinib- and CI-1040-mediated changes in epidermal growth factor receptor signaling in HuCCT-1 human cholangiocarcinoma by serial fine needle aspiration.

Hidalgo M, Amador ML, Jimeno A, Mezzadra H, Patel P, Chan A, Nielsen ME, Maitra A, Altiok S. Hidalgo M, et al. Among authors: altiok s. Mol Cancer Ther. 2006 Jul;5(7):1895-903. doi: 10.1158/1535-7163.MCT-05-0525. Mol Cancer Ther. 2006. PMID: 16891476

7

Optimizing the development of targeted agents in pancreatic cancer: tumor fine-needle aspiration biopsy as a platform for novel prospective ex vivo drug sensitivity assays.

Rubio-Viqueira B, Mezzadra H, Nielsen ME, Jimeno A, Zhang X, Iacobuzio-Donahue C, Maitra A, Hidalgo M, Altiok S. Rubio-Viqueira B, et al. Among authors: altiok s. Mol Cancer Ther. 2007 Feb;6(2):515-23. doi: 10.1158/1535-7163.MCT-06-0388. Mol Cancer Ther. 2007. PMID: 17308050

8

A novel pharmacodynamic approach to assess and predict tumor response to the epidermal growth factor receptor inhibitor gefitinib in patients with esophageal cancer.

Altiok S, Mezzadra H, Jagannath S, Tsottles N, Rudek MA, Abdallah N, Berman D, Forastiere A, Gibson MK. Altiok S, et al. Int J Oncol. 2010 Jan;36(1):19-27. Int J Oncol. 2010. PMID: 19956829 Free PMC article.

9

Adipocyte differentiation: a transcriptional regulatory cascade.

Brun RP, Kim JB, Hu E, Altiok S, Spiegelman BM. Brun RP, et al. Among authors: altiok s. Curr Opin Cell Biol. 1996 Dec;8(6):826-32. doi: 10.1016/s0955-0674(96)80084-6. Curr Opin Cell Biol. 1996. PMID: 8939673 Review.

10

Regulation of gene expression in mammary epithelial cells by cellular confluence and sequence-specific DNA binding factors.

Altiok S, Groner B. Altiok S, et al. Biochem Soc Symp. 1998;63:115-31. Biochem Soc Symp. 1998. PMID: 9513716

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

49 results

Search Page

Filters